New concepts in coagulation

Critical Reviews in Clinical Laboratory Sciences

Volumn 34, Issue 5, 1997, Pages 475-501

  Rock, Gail ^a   Wells, Phil ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Blood coagulation; Endothelium; Extrinsic pathway; Factor XIa; Plasma; Platelets

Indexed keywords

ACTIVATED PROTEIN C; BLOOD CLOTTING FACTOR 11A; BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 7; CELL ADHESION MOLECULE; ENDOTHELIN; ENDOTHELIUM DERIVED RELAXING FACTOR; PADGEM PROTEIN; PLASMA PROTEIN; THROMBOCYTE ANTIGEN; THROMBOMODULIN; THROMBOPLASTIN; TISSUE FACTOR PATHWAY INHIBITOR;

BLOOD CLOTTING; CELL SURFACE; ENDOTHELIUM; FLOW CYTOMETRY; GENE MUTATION; INFLAMMATION; MOLECULAR GENETICS; PRIORITY JOURNAL; PROTEIN ANALYSIS; REVIEW; THROMBOCYTE ACTIVATION; VEIN THROMBOSIS;

EID: 0030733441     PISSN: 10408363     EISSN: None     Source Type: Journal    
DOI: 10.3109/10408369709006423     Document Type: Review

References (60)

1. Marmur JD, Rossikhina M, Guha A, et al. Tissue factor is rapidly induced in arterial smooth muscle after balloon injury. J Clin Invest 1993; 91: 2253.
2. Neuenschwander PF, Morrisey JH. Deletion of the membrane anchoring region of tissue factor abolishes autoactivation of Factor VII but not cofactor function. J Biol Chem 1992; 267: 14477.
3. Rao LV, Rapaport SI. Activation of Factor VII bound to tissue factor: a key early step in the tissue factor pathway of blood coagulation. Proc Natl Acad Sci USA 1988; 85: 6687.
4. Nemerson Y, Repke D. Tissue factor accelerates the activation of Factor VII: the role of a bifunctional coagualation factor. Thromb Res 1985; 40: 351.
5. Hoffman M, Monroe DM, Oliver JA, et al. Factor IXa and Xa play distinct roles in tissue factor-dependent initiation of coagulation. Blood 1995; 86: 1794-801.
6. Kawakami S, Kaibara M, Kawamoto Y, et al. Rheological approach to the analysis of blood coagulation in endothelial cell-coated tubes: activation of the intrinsic reaction on the erythrocyte surface. Biorheology 1995; 32: 521-36.
7. Ten Cate H, Blemond BJ, Levi M, et al. Factor XIa induced activation of the intrinsic cascade in vivo. Thromb Haemostasis 1996; 75: 445-9.
8. Kazama Y, Hamamoto T, Fosters DC, et al. Hepsin, a putative membrane- associated serine protease, activates human Factor VII and initiates a pathway of blood-coagulation on the cell surface leading to thrombin formation. J Biol Chem 1995; 270: 66-72.
9. Lindo VS, Kakkar VV Melissari E. Cleaved antithrombin (Ate): a new marker for thrombin generation and activation of the coagulation system. Br J Haematol 1995; 89: 157-62.
10. Wun T, Kretzmer K, Girard T, et al. Cloning and characterization of a cDNA coding for the lipoprotein associated coagulation inhibitor shows that it consists of three tandem Kunitz-type inhibitory domains. J Biol Chem 1988; 263: 6001-4.
11. Broze GJ, Girard TJ Novotny WF. Regulation of coagulation by a multivalent Kunitz- type inhibitor. Biochemistry 1990; 29: 7539-46.
12. Broze GJ, Jr. Tissue factor pathway inhibitor and the current concept of blood coagulation (review). Blood Coagulation Fibrinolysis 1995; 6(Suppl 1): S7-1.
13. Girard TJ, Broze GJJ. Tissue factor pathway inhibitor. Methods Enzymol 1993; 222: 195-209.
14. Kisiel W. Human plasma protein C. Isolation, characterization, and mechanism of activation by alpha-thrombin. J Clin Invest 1979; 64: 761.
15. Regan LM, Stearns-Kurosawa DJ, Kurosawa S, et al. The endothelial cell protein C receptor. Inhibition of activated protein C anticoagulant function without modulation of reaction with proteinase inhibitor. J Biol Chem 1996; 271;29: 17499-503.
16. Bertina RM, Koeleman BP, Koster T, et al. Mutation in blood coagulation Factor V associated with resistance to activated protein C (see comments). Nature 1994; 369: 64-7.
17. Pryzdial ELG, Bajzar L Nesheim E. Prothrombinase components can accelerate tissue plasminogen activator-catalyzed plasminogen activation. J Biol Chem 1995; 270;30: 17871-7.
18. Wright JH. The origin and nature of blood platelets. Boston Med Surg J 1906; 154: 643-5.
19. Chapman D, Benga G. Biomembrane fluidity-studies of model and natural membranes. In: Chapman D, ed. Biological Membranes Vol. 5, Pp. 1-56. Academic Press, London, 1984.
20. Pollock WK, Rink T Irvine RF. Liberation of 3H arachidonic acid and changes in cytosolic free calcium in fura-2-loaded human platelets stimulated by conomycin and collagen. Biochem J 1986; 235: 869-77.
21. Nurden AT. Glycoprotein defects responsible for abnormal platelet function in inherited platelet disorders. In: George JN, Nurden AT Phillips DR, eds. Platelet membrane glycoproteins. Pp. 357-92. New York: Plenum, 1985.
22. Caen JP, Nurden AT, Jeanneau C, et al. Bernard-Soulier syndrome, a new platelet glycoprotein abnormality. Its relationship with platelet adhesion to subendothelium and with the Factor VIII von Willebrand protein. J Lab Clin Med 1976; 87: 586-96.
23. Bevilacqua MP, Nelson RM. Selectins. J Clin Invest 1993; 91: 370.
24. Lawrence MB, Springer TA. Leukocytes roll on a selectin at physiologic flow rates: distinction from the prerequisite for adhesion through integrins. Cell 1991; 65: 859.
25. Roth GJ. Platelets and blood vessels: the adhesion event. Immunol Today 1992; 13: 100.
26. De Bruijne Admiralal LG, Modderman PW, Von dem Borne AE, et al. P-selectin mediates Ca(2+)-dependent adhesion of activated platelets to many different types of leukocytes: detection by flow cytometry. Blood 1992; 80: 134.
27. Buttrum SM, Hatton R Nash GB. Selectin-mediated rolling of neutrophils on immobilized platelets. Blood 1993; 82: 1165.
28. Yeo EL, Gemmell CH, Sutherland DR, et al. Characterization of canine platelet P- selectin (CD 62) and its utility in flow cytometry platelet studies. Comp Biochem Physiol B 1993; 105: 625.
29. Mulligan MS, Watson SR, Fennie C, et al. Protective effects of selectin chimeras in neutrophil-mediated lung injury. J Immunol 1993; 151: 6410.
30. Carolan EJ, Casale TB. Effects of neutropeptides on neutrophil migration through noncellular and endothelial barriers. J Allergy Clin Immunol 1993; 92: 589.
31. Mulligan MS, Miyasaka M, Tamatani T, et al. Requirements for L-selectin in neutrophilmediated lung injury in rats. J Immunol 1994; 152: 832.
32. Winn RK, Liggitt D, Vedder NB, et al. Anti-P-selectin monoclonal antibody attenuates reperfusion injury to the rabbit ear. J Clin Invest 1993; 92: 2042.
33. Kishimoto A, Takai Y, Mon T, et al. Activation of calcium and phospholipid-dependent kinase by diacylglycerol: its possible relation to phosphatidyl inositol turnover. J Biol Chem 1980; 255: 2273-6.
34. Shattil SJ, Cooper RA. Membrane microviscosity and human platelet function. Biochemistry 1976; 15: 4832-7.
35. Lyal F, Greer IA, Boswel F, et al. The cell adhesion molecule VCAM-1 is selectively elevated in serum in pre-eclampsia: does this indicate the mechanism of leukocyte activation? Br J Obstet Gynaecol 1994; 101: 485-7.
36. McIntyre TM, Zimmerman GA Satoh K. Human endothelial cells synthesize both platelet-activating factor and prostacyclin in response to histamine, brady-kinin and adenosine triphosphate. J Clin Invest 1985; 76: 275-80.
37. Byrnes JJ, Moake JL. Thrombotic thrombocytopenic purpura and the hemolytic- uremic syndrome: evolving concepts of pathogenesis and therapy Clinics in Haematology 1986; 15: 413-42.
38. Mannucci PM, Lombardi R, Lattuada R, et al. Supranormal von Willebrand factor multimers in scleroderma. Blood 1989; 74: 978-83.
39. Furchgott RF, Zawadski JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholin. Nature 1980; 288: 373-6.
40. Marcum JA, Kenny JB Rosenberg RD. Acceleration of thrombin-antithrombin complex formation in rat hindquarters via heparin-like molecules bound to the endothelium. J Clin Invest 1984; 74: 341-50.
41. Bowie EJW. Lipid-related clotting reactions of clinical significance. Arch Pathol Lab Med 1992; 116: 1345-9.
42. Van Hinsbergh VWM. Regulation of the synthesis and secretion of plasminogen activatoars by endothelial cells. Haemostasis 1988; 18: 307-27.
43. Habib A, Maclouf J. Comparison of leukotriene A4 metabolism into leukotriene C4 by human platelets and endothelial cells. Arch Biochem Biophys 1992; 298: 1-9.
44. Marcus AJ, Safier LB. Thromboregulation: multicellular modulation of platelet reactivity in hemostasis and thrombosis. FASEB J 1993; 7: 516-22.
45. Marcus AJ. Eicosanoid interactions between platelets, endothelial cells, and neutrophils. Method Enzymol 1990; 187: 585-98.
46. Nicosia S, Patrano C. Eicosanoid biosynthesis and action: novel opportunities for pharmacological interventions. FASEB J 1989; 3: 1941-8.
47. Ernst E, Hammerschmidt DE, Bagge U, et al. Leukocytes and the risk of ischemic diseases. JAMA 1987; 257: 2318-24.
48. Evangelista V, Rajtar G, de Gaetano G, et al. Platelet activation by fMLP-stimulated polymorhonuclear leukocytes: the activity of cathepsin G is not prevented by antiproteinases. Blood 1991; 77: 2379-88.
49. Molino M, Blanchard N, Belmonte E, et al. Proteolysis of the human platelet and endothelial cell thrombin receptor by neutrophil-derived cathepsin G. J Biol Chem 1995.
50. Skinner MP, Lucas CM, Burns GF, et al. GMP-140 binding to neutrophils is inhibited by sulfated glycans. J Biol Chem 1991; 266: 5371-4.
51. Colli S, Tremoli E. Multiple effects of dipyridamole on neutrophils and mononuclear leukocytes: adenosine-dependent and adenosine-independent mechanisms. J Lab Clin Med 1991; 118: 136-45.
52. Narayanan S. Preanalytical aspects of coagulation testing (review). Haematologica 1995; 80(Suppl): 1-6.
53. Bauer KA, Barzegar S Rosenburg RD. Influence of anticoagulants used for blood collection on plasma prothrombin, fragment F1+2 measurements. Thromb Res 1991; 63: 617.
54. Weitz J, Cruikshank M, Thong B, et al. Human tissue-type plasminogen activator releases fibrinopeptides A and B from fibrinogen. J Clin Invest 1988; 82: 1700.
55. Azola GP, Magoni M, Ascari E, et al. Early prognostic factors in ischaemic stroke. The role of protein C and protein S. Stroke 1993; 24: 1496-500.
56. Israels SJ, Seshia SS. Childhood stroke associated with protein C or S deficiency. J Paeds 1987; 111: 562-4.
57. Kohler J, Kasper J, Witt I, et al. Ischaemic stroke due to protein C deficiency. Stroke 1990; 21: 1077-80.
58. Faioni EM, Franchi F, Asti D, et al. Resistance to activated protein C in nine thrombophilic families: interference in a protein S functional assay. Thromb Haemost 1993; 70: 1067-71.
59. Ayuma H, Ishikawa M Sakiyaki S. Endothelium-dependent inhibition of platelet aggregation. Br J Pharmacol 1986; 80: 411.
60. Coller BS. Platelets in cardiovascular thrombosis and thrombolysis. In: Fozzard HA, Haber E Jennings RB, et al. eds. The heart and cardiovascular system. 2nd ed., New York: Raven, 219-74, 1991.